Omega Fund Management, LLC
Q4 2024 13F Holdings
- Locationboston, MA
- Num holdings
11
- Value ($000)
$120,708
- Date Filed02/14/2025
- Form type13F-HR
- CIK0001637359
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
Bicara Therapeutics Inc. | COMMON STOCK | 055477103 | $38.41M | 32 % | 2,204,650 | ||
NUVB Nuvation Bio | COMMON STOCK CLASS A | 67080N101 | $34.77M | 29 % | 13,072,340 | ||
REPL Replimune Group | COMMON STOCK | 76029N106 | $23.92M | 20 % | 1,975,203 | ||
LXEO Lexeo Therapeutics | COMMON STOCK | 52886X107 | $7.79M | 7 % | 1,184,636 | ||
ALMS Alumis Inc | COMMON STOCK | 022307102 | $5.13M | 4 % | 653,223 | ||
IKNA Ikena Oncology | COMMON STOCK | 45175G108 | $3.69M | 3 % | 2,249,123 | ||
ENGN enGene Holdings Inc. | COMMON STOCK | 29286M105 | $3.50M | 3 % | 526,357 | ||
IMUX Immunic Inc | COMMON STOCK | 4525EP101 | $1.79M | 2 % | 1,788,160 | ||
SANA Sana Biotechnology, Inc. | COMMON STOCK | 799566104 | $1.38M | 1 % | 843,750 | ||
ENGNW enGene Holdings Inc. | WARRANT | 29286M113 | $271.12K | 0 % | 321,502 |
Rows Per Page
10
- 10
- 50
- 100